Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Almirall

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Almirall's 2013 sales performance.

Red Door promotes Matt Lowe and Katy Pogson

Red Door promotes Matt Lowe and Katy Pogson Aldous joined Red Door in 2011 from Red Health as a senior account manager and currently leads accounts for Sanofi, MSD, Baxter, Almirall and Astellas.

EMA backs 15 new medicines for use in EU

EMA backs 15 new medicines for use in EU AstraZeneca and Almirall. There was good news for AstraZeneca (AZ), which received positive opinions for two of its medicines. ... Aclidinium / formoterol fumarate, which is set to be marketed as Brimica Genuair or Duaklir Genuair depending on the country

The M&A trend in pharma

The M&A trend in pharma It is also driving acquisitions that complement the buyer's existing core products, as evidenced by AstraZeneca's $1.2bn acquisition of Almirall's respiratory division and the deal between GSK

Novartis' Ultibro tops Seretide in comparative COPD trial

Novartis' Ultibro tops Seretide in comparative COPD trial With Seretide already succumbing to generic competition and other entrants from AstraZeneca and Forest Laboratories/Almirall also coming through the pipeline, the market is expected to fragment with the new generation

Deal Watch table for July 2014

Deal Watch table for July 2014 2, 700. Almirall/ AstraZeneca. Asset acquisition. Respiratory business including various respiratory assets and device capabilities.

[ Previous 5 results ] 3 4 5 6 7 8 9 10 11 12 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Frontera Group

Welcome to Frontera Group where our agencies immerse you in the world of the patient...

Latest intelligence

Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....
The relevance of patient perspectives to value
Exploring the evolution of patient involvement in health technology assessment, and the role of the patient voice in market access....
How is the NHS Long-term Plan being put into action?
Steve How, Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore some of the changes that have occurred since the plan was published...

Infographics